Objectives: To assess the effect of hip fracture on healthcare utilization among elderly patients. Design: Retrospective cohort study. Setting: Eight general hospitals in Israel, owned by Clalit. Participants: Enrollees >65 years, admitted with a hip fracture during 2009-2013. Main outcome measures: Data collected included demographics, comorbidities, admission details related to the surgical and rehabilitation hospitalizations, mortality and costs. Mean monthly costs before and after the event were compared. Quantile regression was used to analyze associations between patient characteristics and healthcare expenditure in univariate and multivariate analysis. Results: Of 9650 patients admitted with hip fracture during the study period, 6880 (71%) were Clalit enrollees and included in the present study (69% females, median age: 83 years). Total mean monthly costs increased by 96% during the follow-up year ($1470 vs. $749). Costs for rehabilitation accounted for 40% of costs during the first follow-up year. Mean monthly nonrehabilitation costs increased by 21% ($877 vs. $722). Several factors were found to be consistently associated with increased mean monthly costs during the follow-up year. These included Charlson's comorbidity index, hypertension, baseline expenditure in the base year, the location of the fracture, procedure performed, department on admission, admission to the intensive care unit, discharge to a rehabilitation facility and mortality during the follow-up year. Conclusions: Hip fractures in adults in Israel are associated with a significant increase in healthcare utilization and costs. The largest increment was seen in costs for rehabilitation. However, increased costs were noted in all sub-categories of healthcare costs.
Introduction
The incidence of hip fractures is rising, in parallel with the aging of the population and the prevalence of osteoporosis [1] , and is estimated at 400-1 000 per 100 000 per year in the United States [2] .
Performing hip fracture surgery within 48 h has been recommended by the OECD as a quality indicator [3] .
A hip fracture significantly increases mortality to 20-26% within one year following the event [2, [4] [5] [6] [7] [8] . Mortality is six to eight times higher during the first 3 months following the fracture in females and males, respectively, and remains increased for 15 years [4] . Moreover, hip fractures were found to be a major cause of disability, resulting in 1.2 million years of life disabled worldwide [9] and a significant decrease in activity of daily living and instrumental activity of daily living scores. Therefore, most patients require rehabilitation following the acute treatment of the fracture [8] .
Several studies assessed the impact of hip fracture on healthcare utilization and healthcare services costs, and demonstrated a significant increase in healthcare utilization in patients with hip fracture. In those studies, excess costs attributed to the fracture itself were estimated at $20 000-$37 000 per patient during the first year [10] [11] [12] These costs are mainly related to the acute hospital admission, but are also affected by treatment of long-term complications [11] , and the functional disability that leads to repeated visits to rehabilitation centers and increased drug use, including pain medications, which might significantly contribute to drug costs [10] . Among patients with osteoporosis and a hip fracture, the event was associated with a 10-fold increase in healthcare-related costs during the year following the fracture, in comparison to a matched cohort without a fracture (4 014$ vs. 446$; P < 0.01). Total healthcare-related costs were almost doubled in the year following the fracture (15 942$ vs. 8 314$, P < 0.01) [10] .
Most of these studies were conducted in the USA. However, expenditure and cost analyses are often difficult to generalize between countries, due to differences in healthcare systems and in actual treatment costs. In contrast with the private healthcare system in the USA, Israel has a public healthcare system, where pricing of healthcarerelated costs is highly regulated by the Israeli Ministry of Health.
In light of these major differences, we designed a study to evaluate these parameters in Israel, in patients enrolled in Clalit, the largest healthcare provider organizations in Israel, with 4.45 million enrollees.
The main objective of this study was to assess the effect of hip fracture on healthcare utilization and costs in Clalit enrollees over the age of 65 years. This includes total monthly costs and costrelated sub-categories such as costs for rehabilitation, clinic visits, hospitalization for any reason and drug utilization. In addition, we examined other demographic and clinical characteristics and assessed their impact on healthcare utilization following an event of hip fracture.
Methods and Materials
The study population included Clalit enrollees hospitalized due to hip fracture (ICD-9-CM codes 820.XX) during 2009-2013 in any of eight general hospitals owned by Clalit. Data were extracted regarding demographics, underlying diagnoses, Charlson's comorbidity index (CCI), lifestyle factors (alcohol abuse, smoking) and chronic medications. Additional data included the location of the fracture, the type and timing of surgery, the length of surgery, complications (blood loss, described in the operative report, transfer to the intensive care unit and reoperations during hospitalization), destination at discharge and mortality.
The acute hospitalization due to hip fracture was defined as the index hospitalization. The 'base year' was defined as the 365 days prior to hospital admission and the 'follow-up year' was defined as the 365 days following hospital discharge. The primary outcome was the mean monthly costs in the follow-up year, as compared with the mean monthly costs in the base year. Secondary outcomes include sub-categories of healthcare utilization.
Healthcare utilization data and the related costs during the base year were calculated and analyzed according to the following subcategories: inpatient admissions, outpatient visits, emergency department visits, rehabilitation costs, laboratory costs, medication costs, day-care admissions and other costs. Costs in New Israeli Shekels (NIS) were converted to US$ using the mean annual conversion rate of 3.50 NIS per 1 US$ for 2017, as published by the Bank of Israel. Indirect costs were not calculated. Costs were standardized to the 2017 financial year terms using the healthcare expenditure component of the consumer price index, without discounting. We calculated and used mean monthly costs in order to compare costs during the 'base year' (for a full 12 months period) and the 'follow-up year' (for X months, depending on survival). This was performed because looking at annual expenditure could bias total costs in the hip fracture population, since we expected~20% mortality during the first year following discharge.
Statistical analysis
Data were analyzed using SPSS for Windows, version 22 and Stata for Windows, version 12. Descriptive statistics were performed on all data variables. Nominal variables were described using distributions in percentages. Normally distributed continuous variables were described using mean and standard deviation and non-normally distributed variables were described using median and interquartile range. Identification of differences between the base year and followup year was performed using paired t-tests for normally distributed continuous variables. Univariate analysis was performed to identify associations between patient characteristics and healthcare utilization during the follow-up year. This was performed separately for patients with low, median and high healthcare utilization (25th, 50th and 75th percentile) using univariate quantile regression, which allows investigating various percentiles of the costs' distribution and identifying differences in how the parameter influences various percentiles [13, 14] during the follow-up year in order to assess the impact of these variables on healthcare utilization.
For the multivariate analysis of the primary outcome we again used quantile regression. Survival analysis was performed using the Kaplan-Meier method (for univariate analysis) while discrepancies between the groups were identified with the log rank test.
The study was approved by the Institute Review Board of Meir Medical Center and by the Committee for Data Extraction at the General Management of Clalit. Patients' informed consent was waived due to the retrospective nature of the study. The majority of the patients (69.1%) were females. Median age was 83 years. The most frequent comorbidities were hypertension (80.2%), hyperlipidemia (73.8%) and diabetes mellitus (35.4%). 21.5% of the patients had a previous stroke and 4.2% had a previous hip fracture (Table 1) . Mean CCI score was 3.3 ± 2.6. The majority of the patients underwent surgery for the hip fracture during the index hospitalization (91.9%). Most of the fractures were either transcervical (35.3%) or trochanteric (38.6%). Most patients underwent closed reduction of the fracture with internal fixation (32.6%), partial hip replacement (30.0%) or Richard's hip nailing procedure (27.0%). Two-thirds of the patients underwent surgery in <48 h of admission, while the mean time to surgery was 49.9 ± 54.3 h. About 11% required ICU hospitalization and 1.7% underwent re-operation during the hospital admission.
Results

Patient characteristics
Post-operative and survival data
The median length of stay (LOS) was 8 days. In-hospital mortality was 2.9%. Among patients who survived the index hospitalization, most were discharged home (70.8%), while 26.3% were discharged to rehabilitation. Kaplan-Meier estimates of survival were 78.8 and 43.5% at 1 and 5 years, respectively. Survival was better for females than for males (5-year survival: 47.9 vs. 33.6%, P < 0.001) and decreased with age (5-year survival: 63.1, 49.6 and 28.9% for age groups of 65-74, 75-84 and >85 years, respectively, P < 0.001).
Healthcare utilization and healthcare-related costs Figure 1 demonstrates the changes in mean monthly healthcarerelated costs in the base year and the follow-up year, in USD. Total mean monthly costs increased by 96% ($1 634 vs. $833, 5 719 vs. 2914 NIS, P < 0.001). Most of this increase was attributed to a 2 082% increase in mean monthly costs for rehabilitation ($660 vs. $30, 2 310 vs. 105 NIS, P < 0.001). Excluding rehabilitation costs, mean monthly costs were still 21% higher in the follow-up year ($975 vs. $803, 3 413 vs. 2 811 NIS, P < 0.001). This increase was attributed to an increase in inpatient costs (11% increase, $750 vs. $678, 2 624 vs. 2 373 NIS, P < 0.001), outpatient costs (160% increase, $134 vs. $52, 468 vs. 180 NIS, P < 0.001), day-care admissions (11% increase, $59 vs. $53, 205 vs. 184 NIS, P < 0.001), ED visits (27% increase, $12 vs. $9.4, 42 vs 33 NIS, P < 0.001), costs for laboratories (27% increase, $6.9 vs. $5.4, 24 vs. 19 NIS, P < 0.001) and medications costs (50% increase, $1.7 vs. $1.1, 6 vs. 4 NIS, P < 0.001, Fig. 1 ).
Healthcare expenditure was higher for males; mean monthly costs in the base year were $960 (3361 NIS) and $776 (2715 NIS) for males and females, respectively (P < 0.001). During the followup year, a 107 and 91% increase in total mean monthly costs was seen for males and females, respectively 
Factors associated with costs
The univariate analysis for mean monthly costs in the follow-up year is presented in Table 2 Factors consistently associated with increased costs were male sex, higher CCI, liver cirrhosis, diabetes, hypertension, current smoking, history of stroke, medications (corticosteroids, progesterone, proton-pump inhibitors and vitamin K antagonists), baseline costs in the year before admission, the location of the fracture, length of surgery, time to surgery, LOSs in the orthopedics and intensive care unit, re-operation, costs of the index hospitalization and mortality ( Table 2) .
A multivariate quantile regression model for mean monthly costs in the follow-up year is presented in Table 3 . Factors consistently associated with increased mean monthly costs were CCI, hypertension, baseline expenditure in the base year, the location of the fracture, the hospital LOS, discharge to a rehabilitation facility and mortality (Table 3) . 
Discussion
Our results demonstrate that hip fracture in the elderly population in Israel is associated with significantly increased healthcare utilization and costs. During the year following a hip fracture, mean monthly costs increased by 96% in comparison to the year before the fracture. Rehabilitation costs comprised of~40% of the total mean monthly costs during the follow-up year. The increments in healthcare expenditures were higher in males as well as in patients who died during the follow-up year, and increased with age. Multivariate regression identified factors associated with increased mean monthly costs during the follow-up year, which included higher CCI score, certain comorbidities, expenditure in the base year, discharge to a rehabilitation facility and mortality. These data correspond with previous studies [2, 5, 7, 8, 15] . A recent study which examined 6019 patients with hip fracture and assessed costs before and after hospital admission [11] , showed that healthcare expenditure increased by 147% during the year following the fracture. Of these costs, 64% were attributed to the acute care of the fracture and 36% to rehabilitation [11] . Similarly, a Canadian study that compared mean annual costs between patients with hip fracture and a matched cohort showed that costs in the hip fracture group increased by 241 and 266% in females and males, respectively [12] . The largest component of costs attributable to the hip fracture was acute hospitalizations, accounting for~40% (38-41%). Similar to our study, higher costs were demonstrated in patients who died during follow-up. Another recent study analyzed healthcare utilization and costs in 8028 patients with hip fracture in the UK [16] . Mean annual costs increased by~135%. Inpatient costs comprised 92% of the total costs during the follow-up year (vs. 83% in the base year). This study also demonstrated that variables associated with significantly higher healthcare costs in the follow-up period after hospitalization included age >65 years, higher CCI score, discharge to another institution, hospitalizations and outpatients visits in the baseline year and male sex [16] . Another American study [17] demonstrated a 400% increase in mean healthcare expenditures in the year following hip fracture. Approximately 88% of this increment has been directly related to the hip fracture. Healthcare expenditures increased in all sub-categories of healthcare utilization, except cancer treatment-related costs. These include costs for treatment directly related to the fracture (aftercare, complications, decubitus ulcers) and costs for treatment unrelated to the fracture (cardiovascular, respiratory) [17] . Although differences exist in study designs and setting, all these studies show similar trends: healthcare utilization is at least doubled in the year following a hip fracture. Indeed, in the present study, costs for rehabilitation accounted for <50% of the total costs during the follow-up year.
Some of the economic effects demonstrated in this study are quite expected. Hip fracture requires rehabilitation in the majority of cases. Functional health status limitations were previously [5] found in all ADL categories among patients with hip fracture in comparison to controls. Thus, it is no surprise that costs for rehabilitation increased dramatically in the present study. However, we have shown that mean monthly costs have increased in all subcategories of healthcare utilization during the follow-up year, with a 21% increase in non-rehabilitation costs. A question arises regarding how much of this increase in costs is attributed to the fracture itself. Following the hip fracture, 51% of the patients were found to be physically frail and 34% were disabled (defined as any ADL dependency) [18] . Some degree of cognitive impairment was found in 89% of the patients. Complications were seen in 71% of patients with frailty and cognitive impairment [18] . It was recently shown that patients with frailty utilize healthcare services to a greater extent in comparison to matched patients without frailty [19] . This includes increased general practitioner and outpatient visits, hospitalizations and nursing care. Assuming that a certain proportion of patients have physical and/or cognitive frailty following a hip fracture, it is possible that frailty accounts for a portion of the increased costs during the following year. Therefore, frailty should be a target for rehabilitation, monitoring and treatment, both from the patient safety and quality of life perspective, and from the economic perspective. Another factor to be considered is aging. According to Clalit HMO's database, healthcare utilization in the general population increases in~2% per year, due to aging alone. Therefore, the much higher increase in costs seen in the present study is unlikely to be explained by aging alone.
Patients who died during the follow-up year had the largest increase in healthcare-related costs. One can assume that they were in a poorer post-and maybe pre-fracture medical condition, and probably required more intensive medical care following the fracture.
The present study has some strengths, including a large sample size, accurate billing information collected directly from an administrative database, complete follow-up for all Clalit enrollees included in the study, both in the hospital and in the community settings, and a unique opportunity to explore this topic in a public healthcare system with government dictated healthcare services coverage.
Our study has several limitations. Costs were calculated according to Clalit's database, which includes only direct costs. These costs are either calculated based on the LOS with a per-diem cost, or based on a prospective payment diagnosis-related group-like mechanism, where several procedure codes are compensated on a global basis. However, this method does not take into account detailed costs of procedures (e.g. magnetic resonance imaging) or costly medications (e.g. broad-spectrum antibiotics) given during hospital admission. In addition, indirect costs, such as loss of work days, home assistance that may be required for some patients, and supportive medical devices not covered by the HMO, were not taken into account in our calculations. No quality of life data were obtained, thus the impact of hip fracture on this parameter and interrelations between it and healthcare utilization were not assessed. Some Clalit hospitals have a rehabilitation facility within them. Thus, in some hospitals, costs for rehabilitation (at least partially) were included in the costs for the index hospitalization. This means that at least some of the costs for the index hospitalization are actually attributed to rehabilitation. The study included only Clalit enrollees; however, since most of the basic medical coverage in Israel is dictated by the Ministry of Health, we can assume that costs for these services apply to the other three HMOs in Israel, as well. Finally, some demographic differences between Clalit enrollees and enrollees in the other three HMOs cannot be ruled out.
To conclude, our study demonstrates that hip fracture in patients over 65 years of age is associated with a significant increase in total mean monthly costs during the follow-up year, for all examined sub-categories of costs. As the population worldwide is aging and life expectancy increases, it is reasonable to assume that the incidence of hip fractures, and the economic burden it brings, will only increase in the future. Additional study is therefore required to further characterize this increase in costs and to find and define modifiable factors that may affect these changes in healthcare utilization following a hip fracture.
